Gergely Gulyás, the head of the Prime Minister’s Office, asked European Commissioner Stella Kyriakides in a letter on Friday to facilitate publication of the European Union’s agreements with coronavirus vaccine producers and the timeframe of vaccine shipments.
In his letter, published on Facebook, Gulyas said that Hungary’s vaccination programme was being implemented “in a disciplined and scheduled manner”. He noted that Hungary was using Chinese and Russian vaccines, too, and over 1.2 million people had received their first shots.
He wrote that in order to maintain public trust,
the government had published its agreements with Russia and China,
including details of volume and shipping schedules, but added that “this information is not available for Hungarian citizens in the case of vaccines procured by the EU”. He insisted that the “Hungarian public is entitled to be fully informed about the content of the contracts, especially about the delivery schedule”.
Gulyas said the Hungarian government was “convinced that in these difficult times, all decision-makers must act with the greatest possible responsibility and care, not only at national but also European level …
we have to work closely together and support each other”.
- Coronavirus – Hungary to publish vaccine procurement contracts
- Hungary contracts 12 million doses of vaccine for nearly 100 million euros – UPDATE
- Austria and Denmark plan vaccines with Israel to bolster slow EU supply
As we reported before, Hungary’s government announced on March 11 that they would make their contracts on procuring the Sputnik V and Sinopharm vaccines available for the public by Friday. They called then the European Union to allow publication of European Commission contracts too.
Brussels “banned” the publication of those contracts, Gergely Gulyás told a regular news conference on Thursday. He added that he had turned to the “commissioner responsible” to allow member states to make the EC’s vaccine contracts also publicly available. On the country’s vaccination plan Gulyás said
“the Hungarian government will be able to have everyone vaccinated in the first half of the year”,
and will therefore order vaccines for the second half only if “it is absolutely necessary”.
The vaccines contracted so far would suffice to inoculate one-and-a-half times more people than the entire population of Hungary, he said. “We have ordered everything slated to arrive in the first half of the year, and passed on some [vaccines] which would only be delivered in the second half, especially towards the end of the year,” he said, adding that the EC’s “claims” on the issue were “untrue and therefore unacceptable.”
Source: MTI
please make a donation here
Hot news
Deadly H5N1 virus spreads in Hungary again
Attention! Wizz Air to impose more fines for oversized baggage
German companies in Hungary worried about growing costs, decreasing consumption
Budapest Christmas markets open with moderate prices and discounts for tourists today
Hungary’s relations with Armenia developing after decade-long freeze
PM Orbán will build Europe’s most modern border crossing, sets finish date for 160 km/h railway line
2 Comments
Stella Kyriakides will NOT cooperate with the request from Hungary’s Government to publish European Commission COVID-19 vaccine contracts.
Remember that she is nothing but a glorified observer of behavioural patterns in captive mice and – as such – her intelligence does not extend above the level of her rodent subjects.
To release such sensitive documentation requires a certain level of mental capacity which – unfortunately for Europe – she totally lacks.
What about Hu Govt publishing all the details of its ridiculous purchase deal of Sinopharm vaccine? How much paid and to whom…. So far all we taxpayers know, and certainly not from Hu Govt and its many media…, is that Hungary paid a fortune of our money, and in total secrecy ( very suspicious of course ) for a lousy vaccine whose side effects and third phase of experimentation have been kept secret by Sinopharm and which apparently requires God only knows how many shots to be even just slightly effective, a fortune which is several times more than market price and several times more than the EU paid for far more effective vaccines that Sinopharm’s.